The global medical devices industry is undergoing a major transformation in business models, technology adoption, and care delivery approaches.
The global medical devices industry is undergoing a major transformation in business models, technology adoption, and care delivery approaches. The digitalization of medical devices encourages medtech players to deliver value for providers and patients with devices and digital data. This is leading to the development of new business models, such as platform plays, and holistic care delivery approaches that will accelerate global medical devices market growth. Under an aspirational scenario, the market will likely reach $464.54 billion by the end of 2022 from $425.21billion in 2021, according to Frost & Sullivan’s recent analysis, Global Medical Devices Outlook.
“The unprecedented labor shortage due to the COVID-19 pandemic will drive hospitals to seek and adopt operational and clinical efficiency solutions,” said Suchismita Das, Healthcare & Life Sciences Senior Industry Analyst at Frost & Sullivan. “Additionally, insight-as-a-service offerings will emerge as pioneering medtech companies are transforming into health-tech players while looking for the next level of growth through their platform strategies.”
Das added that the entry of disruptive start-ups and pure technology firms into the care provision space has intensified competition. “As a result, medtech giants are exploring options to build assets in the digital arena through mergers and acquisitions (M&As) to better compete and sustain revenue growth,” she said.
Hospitals increasing investments in advanced technologies to improve patient outcomes and operational efficiencies will present opportunities for medical devices market participants, including: